Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 1

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 1
---
 any sales of these securities in any state in which such offer, solicitation or sale be unlawful before registration or qualification under the laws of any such state.

| OFFERING CIRCULAR |     | ACCREDITED     
 INVESTORS ONLY |

<div align='center'>DATED SEPTEMBER 8, 2025

REGEN BIOPHARMA, INC.

Up to 25,000,000 Shares of Common Stock

Offering under Tier 2 of Regulation A+ of the Securities and Exchange Commission

25,000,000 Shares of Common Stock, $0.0001 Par Value,

Offering Amount: A Maximum of $250,000
Price: $.01 per share of Common Stock

Minimum Purchase Amount: 0

Sales will be made to Accredited Investors Only</div>

You may only rely on the information contained in this Offering Circular or that we have referred you to. We have not authorized anyone to provide you with different information. This Offering Circular does not constitute an offer to sell or a solicitation of an offer to buy any securities other than the common stock offered by this Offering Circular. This Offering Circular does not constitute an offer to sell or a solicitation of an offer to buy any common stock in any circumstances in which such offer or solicitation is unlawful. Neither the delivery of this Offering Circular nor any sale made in connection with this Offering Circular shall, under any circumstances, create any implication that there has been no change in our affairs since the date of this Offering Circular is correct as of any time after its date.

There is no minimum proceeds threshold for the offering. The offering will commence within two days of qualification by the United States Securities and Exchange Commission and will terminate nine months after qualification . The Company will retain all proceeds received from the shares sold in this offering. The Company has not made any arrangements to place the proceeds in an escrow or trust account. Any proceeds received in this offering may be immediately used by the Company in its sole discretion. There are no minimum purchase requirements for each investor. All proceeds retained by the Company may not be sufficient to continue operations.

THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. BEFORE INVESTING, YOU SHOULD CAREFULLY READ THIS OFFERING CIRCULAR AND, PARTICULARLY, THE RISK FACTORS SECTION, BEGINNING ON PAGE 8.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETER